Literature DB >> 24591037

FDA-approved Next-Generation sequencing system could expand clinical genomic testing: experts predict MiSeqDx system will make genetic testing more affordable for smaller labs.

.   

Abstract

Mesh：

Year:  2014        PMID： 24591037     DOI： 10.1002/ajmg.a.36461

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN： 1552-4825            Impact factor:   2.802


× No keyword cloud information.
  3 in total

1.  Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.

Authors:  Daoud Sie; Peter J F Snijders; Gerrit A Meijer; Marije W Doeleman; Marinda I H van Moorsel; Hendrik F van Essen; Paul P Eijk; Katrien Grünberg; Nicole C T van Grieken; Erik Thunnissen; Henk M Verheul; Egbert F Smit; Bauke Ylstra; Daniëlle A M Heideman
Journal:  Cell Oncol (Dordr)       Date:  2014-09-11       Impact factor: 6.730

2.  The audacity of interpretation: Protecting patients or piling on?

Authors:  Misha Angrist
Journal:  Appl Transl Genom       Date:  2014-09-01

Review 3.  Developing genomic knowledge bases and databases to support clinical management: current perspectives.

Authors:  Vojtech Huser; Murat Sincan; James J Cimino
Journal:  Pharmgenomics Pers Med       Date:  2014-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.